Silybin (SB), a constituent of the medicinal plant Silybum marianum, is reported to be a potent hepatoprotective agent, but little is currently known regarding its genotoxicity, mutagenicity and potential chemopreventive properties. In this study, we evaluated the ability of SB to induce DNA migration and micronuclei (MN) formation in human hepatoma cells (HepG2). Also, possible preventive effects of SB on MN formation induced by three different mutagens, bleomycin (BLEO), benzo[a]pyrene (B[a]P) and aflatoxin B 1 (AFB 1 ), were studied. To clarify the possible mechanism of SB antimutagenicity, three treatment protocols were applied: pretreatment, in which SB was added before the application of the mutagens; simultaneous treatment, in which SB was added during treatment and post-treatment, in which SB was added after the application of the mutagens. At concentrations up to 100 mM, SB was nongenotoxic, while at a concentration of 200 mM, SB induced DNA migration, generated oxidized DNA bases, reduced cell viability, decreased the replicative index of the cells and induced oxidative stress. It is noteworthy that SB was able to reduce the genotoxic effect induced by B[a]P, BLEO and AFB 1 in pretreatment and simultaneous treatments but had no significant effect on DNA damage induction in posttreatment. Taken together, our findings indicate that SB presents anti-genotoxic activity in vitro, which suggests potential use as a chemopreventive agent.
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Introduction
In the last few decades, many health claims have been made for compounds derived from vegetables, fruits and plants. This interest has led to a rise in the number of studies aiming to identify and characterize the biological effects of the active compounds of natural substances (1) .
Originating in the Mediterranean basin, Silybum marianum (commonly called milk thistle), is a medicinal plant that has been used for centuries in the treatment of liver diseases. Silymarin, an extract isolated from its fruits and seeds, is known to provide a wide range of hepatoprotective effects, especially against diseases like hepatitis, cirrhosis and jaundice (2). Marketed as Legalon or Flavobion, silymarin has been successfully applied in the therapy of various liver diseases. Moreover, a highly efficient antitumour activity was also reported very recently (3) (4) (5) . One of the most active constituents is (þ)-silybin (SB) [(2R,3R)-3,5,7-trihydroxy-2-[(2R*,3R*)-3-(4-hydroxy-3-methoxyphenyl)-2-hydroxymethyl-1,4-benzodioxane-6-yl]-4-chromanone], which is composed of flavanone-3-ol and 1,4-benzodioxane ring systems (SB) (Figure 1 ).
Besides SB's antitumour activity (3) (4) (5) , other studies have shown that it possesses antioxidant (6), anti-inflammatory (7) and antifibrotic (8) properties. SB is also used as an antidote for Amanita phalloides intoxications (9) .
In the present study, the possible genotoxic and antigenotoxic effects of SB against DNA damage induced by bleomycin (BLEO) benzo[a]pyrene (B[a]P) and aflatoxin B 1 (AFB 1 ) in HepG2 cells were assessed using the comet assay and the micronucleus (MN) test. A combination of tests is generally applied to investigate an effect on the main types of DNA damage. The in vitro MN test is a mutagenicity test system for the detection of agents that induce chromosome fragments (clastogenic effect) and/or aneuploidy (aneugenic effect) (10) . For its part, the comet assay (single-cell gel electrophoresis) is a genotoxicity test for detecting primary DNA damage, as opposed to the mutational effects (e.g. structural chromosomal aberrations, MN, gene mutations) that can result from DNA damage (11) . Therefore, the complementary action of these two assays made their combination in the present study both appropriate and useful in evaluating the genotoxicity and/or anti-genotoxicity of SB.
Materials and methods

Cell line
The HepG2 cell line was kindly provided by Dr S. Knasmüller (Institute of Cancer Research, Medical University of Vienna, Vienna, Austria). The cells were stored in liquid nitrogen and cultivated in Dulbecco's minimal essential medium, supplemented with 15% fetal bovine serum, both from Gibco (Paisely, Scotland) and 50 lg/ml penicillin-50 IU/ml streptomycin in 75 cm 2 tissue culture flasks (Greiner, Kremsmuenster, Austria). -free phospate buffered saline (PBS). All other chemicals, reagents and buffers were analytical grade products acquired locally from Pronalisa-Brazil.
Treatments
For the mutagenicity test, HepG2 cells were first grown for a complete cell cycle (24 h ) and then washed twice with PBS. Next, serum-free medium was added to the culture and the test substances were subsequently added for 24-h treatment. In all these experiments, the cells were exposed to SB at concentrations of 0, 0.01, 0.1, 1, 10, 50, 100 and 200 lM plus a positive control with B[a]P (15 lM). At the end of the treatment, the cells were evaluated with different end points.
In the anti-genotoxicity studies, we tested SB against BLEO (10 lg/ml), B[a]P (15 lM) and AFB 1 (1.5 lM). The treatment protocols were the following:
1. Pretreatment-HepG2 cells were first grown for 24 h in normal medium. SB was then added for another 24 h. After that, the cells were washed, serumfree medium was added and the cells were exposed to the mutagen for another 24 h. 2. Simultaneous treatment-cells were grown for a complete cell cycle (24 h) and then washed with PBS. Next, serum-free medium was added, followed by the mutagen and SB for 24 h of treatment. 3. Post-treatment-cells were grown for a complete cell cycle and then washed. MN was induced by a 24-h treatment with B[a]P or AFB1 in serum-free medium. Then, the cells were washed and further incubated in complete medium containing 24-h SB.
Cytotoxicity assay
For cytotoxicity analysis, cells were treated with 0, 0.01, 0.1, 1, 10, 50, 100 and 200 lM concentrations of SB. The cultures were treated for 24 h and afterwards 300 cells were analysed using the Trypan blue exclusion dye method (12) .
MN assay
The MN assays were carried out according to the Darroudi and Natarajan (13) protocol. In order to evaluate the frequency of MN in binucleated human HepG2 cells, cytochalasin B (final concentration 3.0 lg/ml) was added to the medium after treatment and washing. HepG2 cells were fixed after 28 h. For fixation, the cells were trypsinized and treated with cold hypotonic KCl solution (5.6 g/l) and subsequently, air-dried preparations were made. For the detection of MN in binucleated cells, the slides were stained with 5.0% aqueous Giemsa solution. For each experimental point, three cultures were treated in parallel and 1000 cells were evaluated from each culture for MN induction. To study the effects of SB on cell division, the fraction of binucleated cells (%) in relation to the number of mononucleated, tri-and tetranucleated cells was determined (14) .
Comet assay
The single-cell gel electrophoresis assay was carried out according to the protocol of Uhl et al. (15) . Thereafter, $5 Â 10 4 cells were mixed with LMP agarose and then transferred to agarose-coated slides, coverslipped and cooled at 4°C for 20 min. After removal of the coverslips, the slides were immersed in fresh lysis solution composed of 89 ml of lysis stock solution (2.5 M NaCl, 100 mM EDTA, 10.0 mM Tris, pH 10, adjusted with solid NaOH, 890 ml distilled water and 1% sodium lauryl sarcosinate), 1.0 ml Triton X-100 (Merck) and 10 ml dimethyl sulfoxide. Cells were lysed for 1 h at 4 C, in the dark and next, the slides were transferred to an alkaline solution (pH . 13.0; 300 mM NaOH and 1 mM EDTA, prepared from a stock solution of 10 M NaOH and 200 mM EDTA) at 4°C for 40 min to denature DNA. Electrophoresis was run at 25 V and 300 mA (25 V/cm) for 20 min and subsequently, the slides were neutralized with pH 7.5 buffer (0.4 M Tris-HCl) with 3 5-min changes, airdried, fixed in absolute ethanol for 10 min and stored for later scoring. The slides were stained by covering with 100 ll of ethidium bromide (20 lg/ml) and a coverslip and the cells were evaluated with a fluorescence microscope (Nikon) at 40Â, using a 420-490 nm excitation filter and a 520 nm barrier filter. A total of 100 cells per treatment were inspected visually. The comets were classified as the following: Class 0-undamaged cells showing no tail, Class 1-cells with a tail size less than the diameter of the nucleoid, Class 2-cells with a tail size two times longer than the diameter of the nucleoid, Class 3-cells with a tail size greater than twice the diameter of the nucleoid and (Class 4) cells with a tail size greater than three times the diameter of the nucleoid (16) . The total score was calculated as the sum of the number of cells scored for each class multiplied by the value of that class.
Modified comet assay. After lysis, slides for measurement of oxidized bases were washed three times in enzyme buffer (0.1 M KCl, 0.5 mM Na 2 EDTA, 40 mM N-2-hydroxyethylpiperazine-N-2-ethanesulphonic acid and 0.2 mg/ml bovine serum albumin, pH 8.0) and then incubated for 30 min at 37°C with 45 ll of enzyme [Endonuclease III (ENDO III) from Escherichia coli and formamidopyrimidine glycosylase (FPG) from E.coli, Sigma-Aldrich] or 45 ll of enzyme buffer.
Reactive oxygen species production with dichlorofluorescein assay Intracellular reactive oxygen species (ROS) was quantified by using a fluorescent probe and reduced 2¢,7¢-dichlorofluorescein (H 2 DCF) diacetate (DA) (17) . H 2 DCF-DA diffuses through the cell membrane and was enzymatically hydrolyzed by intracellular esterases to form non-fluorescent H 2 DCF, which is oxidized to fluorescent dichlorofluorescein (DCF) by ROS. Thus, DCF fluorescence intensity is proportional to intracellular ROS production. Cells treated with SB were washed once with warm serum-free media and incubated with 10 lM of H 2 DCF-DA in serum-free media (Molecular Probes, Carlsbad, CA, USA) for 30 min at 37°C. Then, cells were washed again and stimulated by adding 1 mM of H 2 O 2 . Fluorescence was measured by fluorometry (excitation 485 nm, emission 538 nm). Results were expressed in relation to values from cells treated with H 2 O 2 . Fig. 1 . Chemical structure of SB. Fig. 2 . DNA migration (a) and cytotoxicity (b) induced by SB in HepG2 cells. Cells were exposed to SB under identical conditions; subsequently, the cells were analysed for cytotoxicity and induction of comets as described in Materials and methods. Bars represent means AE SD of DNA migration obtained with from three cultures per exposure concentration. Cell viability was evaluated with trypan blue and expressed as % of negative control. *Indicates significantly different from the corresponding control (Dunnett's test, P , 0.05). 
Statistical analysis
All comet scores, MN and intracellular ROS percentage are expressed as mean
Results
SB genotoxicity results evaluated using comet assay and cytotoxicity are shown in Figure 2 . The treatment of HepG2 cells with different concentrations of SB led to a significant increase in DNA fragmentation only at the highest concentration (200 lM). SB concentrations ranging from 0.01 to 100 lM did not alter DNA migration significantly. The same regularity was observed in the cytotoxicity of HepG2 cells evaluated by the Trypan blue method.
In order to better clarify this, mechanism of SB induced DNA damage with applied a modified version of the comet assay and the use of the probe 2#,7#-dichlorofluorescein diacetate (DCFH). The modified comet assay results showed that the 200-lM concentration of SB leads to an increase in the number of FPG-and ENDO III-sensitive sites (Figure 3) . Intracellular ROS were quantified and among six concentrations tested. Only the highest was capable of inducing oxidative stress (Figure 4 ). Figure 5 shows the results of the MN assay. None of the concentrations tested led to increased MN frequencies. Although the highest concentration decreased the number of binucleated cells by $30% compared to the control (P , 0.05), this probably indicates a delay in the cell cycle because of a slight cytotoxic effect by SB at the highest concentration.
The effects of SB on the MN-inducing activity of BLEO, B[a]P and AFB 1 are shown in Figure 6 . It can be seen that at concentrations of 0.1, 1 and 10 lM, SB protected against the MN-inducing action of BLEO in simultaneous treatment. The 100-lM SB concentration did not show any protective effect against BLEO-induced MN. In the pretreatment, only 10 and 100 lM of SB presented a protective effect. The post-treatment schedule was not effective at all. Also very similar response was detected with the comet assay, although significant protective effect in the post-treatment schedule was observed ( Figure 7) .
In order to evaluate if the protective effect of this compound is related to its capacity to inhibit free radical induced DNA damage generated by the three mutagens, cells were also treated with FPG and ENDO III. The results are depicted in Figure 8 . It can be seen that all the mutagens induced an increase in the number of FPG-and ENDO III-sensitive sites, in addiction to that the co-administration of 10 lM SB was able to decrease the number of oxidized bases induced by the three compounds. Further analysis of SB antioxidant effect was evaluated using its ability to inhibit H 2 O 2 -induced DCFH oxidation ( Figure 9 ); in this experiment, a clear dose-response relationship was evidenced, being the highest dose tested able to prevent almost 50% of DCFH oxidation. 
Anti-genotoxicity of SB in HepG2 cells
Discussion
In the present study, we investigated the genotoxic mutagenic and also the possible protective effects of SB in HepG2 cells by means of two end points: primary DNA lesions (single and double-strand breaks and alkali-labile sites) with the comet assay and chromosome breakage or loss using the MN test. HepG2 cells are a good model for such investigations since most of the antimutagenicity studies with polyphenols have been carried out with bacterial indicators or rodent cells (Chinese hamster ovary cell and V-79) (18) (19) (20) . On the other hand, it is not known whether these compounds are also protective in human-derived cells. It is noteworthy that the results obtained in bacterial and other in vitro assays with mammalian cells do not necessarily reflect the situation in humans since a characteristic feature of the chemopreventive action of polyphenols is the induction of drug metabolizing enzymes (which are present to some extent in HepG2 cells) (21) .
Our data show that SB induces genotoxic effects in HepG2 cells in the comet assay only at an extremely high concentration (200 lM). This concentration is also slightly cytotoxic. The concentration of 200 lM of SB appears to increase oxidative stress as demonstrated in the evaluation of intracellular ROS. Halliwell (22, 23) suggests that high doses of polyphenols can increase oxidative stress. Burton and Ingold (24) demonstrated that polyphenols might participate in lipid peroxidation as pro-oxidants. The key factors in converting polyphenols from antioxidants to pro-oxidants are the partial pressure of O 2 or the concentration of polyphenols. It is demonstrated in our experiment since SB was able to induce genotoxic and oxidative stress at a high concentration, i.e. SB was able to promote ROS formation and DNA oxidation.
One hypothesis for this oxidation of DNA comes from the ability of some polyphenols to form a ternary complex of SB-DNA-Cu 2þ in the presence of transition metals (such as copper). This can lead to Cu þ formation, which could catalyse the formation of OHÁ radical, leading to DNA oxidation, as evidenced by our comet assay experiment (25) (26) (27) (28) .
The discrepancy between the comet and MN assay results may indicate a difference in the ability of SB to induce primary repairable lesions rather than clastogenic and aneuploidic effects that cannot be repaired (29) (30) (31) .
As far as antimutagenicity is concerned, SB pretreatment at 10 and 100 lM protected against MN formation induced by BLEO, a known generator of ROS (32, 33) . In the simultaneous treatment, concentrations of SB ranging from 0.1 to 10 lM protected HepG2 cells against BLEO-induced MN formation, probably due to the ability of polyphenols to scavenge ROS (34) . The protective effects observed in these experiments reflect the known characteristic of some polyphenols to quench reactive species, like singlet oxygen and OHÁ (34, 35) . It could explain, at least in part, the protective effect against BLEO since this drug is a known ROS generator (32, 33) .
The results obtained with B[a]P showed that pretreatment of HepG2 cells with SB (1, 10 and 100 lM) decreased the number of B[a]P-induced MN, suggesting a modulating effect of SB on cytochrome P450 (CYP) isoenzymes, which are responsible for B[a]P activation (36) . This idea is supported by a recent study by Dvorák et al. (37) that reported the capacity of SB and its analogue dehydrosilybin to inhibit the catalytic activity of CYP1A1 in HepG2 and HaCat cells. Simultaneous treatment presented higher efficiency in protecting against DNA damage, and this could be in part due to the sum of two effects, i.e. inhibition of CYP isoenzymes and also free radical scavenging activities, since it is known that activation of some compound via CYP enzymes could generate ROS through a redox cycle (38) (39) (40) .
Similar to the result obtained with B[a]P, pretreatment of cells with SB led to a decrease in the number of AFB 1 -induced MN. This fact also points to induction or modulation of enzymes involved in the metabolism of this mycotoxin. Kohno et al. (41) showed that rats fed with SB presented higher phase II enzyme (mainly glutathione S-transferase) activity, which could perhaps accelerate the inactivation of AFB 1 .
Furthermore, it remained to be shown if the protective effect of SB against all the mutagens was related to its antioxidant activity. In order to asses this hypothesis, we have treated the cells with the mutagens and with SB and added FPG and ENDO III. As showed in Figure 8 , all the compounds were able to increase oxidative damage. On the other hand, cells treated with the mutagen and 10 lM SB presented the same levels of oxidized bases as the control cells. This set of experiments clearly demonstrate that SB was able to prevent DNA damage caused by ROS possibly generated during drug metabolism.
When the concentrations of SB (1, 10 and 100 lM) were associated with H 2 O 2 , ROS decreased in relation to the positive control. The antiradical properties of polyphenols are directed towards ROS involved in the initiation of lipid peroxidation; moreover, polyphenols are soluble chain-breaking inhibitors of the peroxidation process, acting as scavengers of intermediate peroxyl and alkoxyl radicals and chelating metal ions that are of major importance for the initiation of radical reactions (31, 41) .
Evaluation of anti-genotoxicity with the comet assay demonstrated a pattern of protection in pretreatment and simultaneous treatment similar to that observed in the MN assay. However, when the post-treatment schedule was assessed, concentrations of 1 and 100 lM showed an antigenotoxic effect against BLEO. Only the 1 lM concentration of SB evidenced protective activity when B[a]P and BLEO were used. In these kinds of treatments, when protective action of a tested chemical is observed, the agents act on the physiological mechanisms of DNA protection and repair. Reverting the DNA injury, avoiding mutagenic effects and preventing the fixation of mutations (42) (43) (44) . Therefore, SB did stimulate these mechanisms slightly, which was not observed in the MN assay.
As far as the mechanisms of action of the three mutagens assessed in this study are concerned, SB acts to prevent DNA oxidation mainly by quenching free radicals and modulating biometabolism enzymes (44, 45) . However, other mechanisms of action that are beyond the scope of this study should be considered.
According to the evidence of Ferguson (46) , certain compounds can both induce and prevent DNA damage. Thus, prior to establishing any type of chemopreventive strategy, investigation into the conditions under which such compounds promote benefits and prevent genome damage is required. The present study shows that intermediate SB concentrations may be recommended for use since the lowest dose presented no reduction in the mean MN frequency and the highest concentration evaluated showed genotoxic activity.
In conclusion, our results demonstrated that SB could be a suitable agent for preventing chemically induced DNA damage in vitro. However, further investigations are necessary to explain the modes of chemopreventive action of SB. 
